Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Best Distribution Strategy of Azithromycin for Yaws Eradication (The Yaws 3 Trial)

NCT03490123 is registered in ClinicalTrials.gov with Lihir Medical Centre as lead sponsor.

NCT NCT03490123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03490123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Best Distribution Strategy of Azithromycin for Yaws Eradication (The Yaws 3 Trial)
Lead sponsor
Lihir Medical Centre
Phase
Phase 4
Overall status
Completed
Start date
April 16, 2018
Completion date
April 1, 2020
Enrollment
56,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

yaws